Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
Hepatology Communications
|
April 8, 2020
Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles
Xiao Liu, Sara Brin Rosenthal, Nairika Meshgin, et al.
Gastroenterology
|
December 3, 2016
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Charlie C Park, Phirum Nguyen, Carolyn Hernandez, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 22, 2018
Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS
Anika M Helferich, Sarah J Brockmann, Jörg Reinders, et al.
Brain : a Journal of Neurology
|
December 11, 2025
Somatic gene mutations in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
Óscar González-Velasco, Rosanna Parlato, Rüstem Yilmaz, et al.
Journal of Gastroenterology and Hepatology
|
October 5, 2017
The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury
Ronald G Thurman, Blair U Bradford, Yuji Iimuro, et al.
Acta Neuropathologica
|
November 19, 2015
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Corinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, et al.
The Journal of Clinical Investigation
|
August 4, 2006
The Clinical Research Forum and Association of American Physicians disagree with criticism of the NIH Roadmap
William Crowley, John Courtney, Larry Jameson, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
Elisabeth H Vollmann, Lizhi Cao, Aldo Amatucci, et al.
Alimentary Pharmacology & Therapeutics
|
March 22, 2024
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease
Rohit Loomba, Ginger Clark, Jeff Teckman, et al.
Alimentary Pharmacology & Therapeutics
|
February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Luis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
Hepatology Communications
|
April 8, 2020
Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles
Xiao Liu, Sara Brin Rosenthal, Nairika Meshgin, et al.
Gastroenterology
|
December 3, 2016
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Charlie C Park, Phirum Nguyen, Carolyn Hernandez, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 22, 2018
Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS
Anika M Helferich, Sarah J Brockmann, Jörg Reinders, et al.
Brain : a Journal of Neurology
|
December 11, 2025
Somatic gene mutations in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
Óscar González-Velasco, Rosanna Parlato, Rüstem Yilmaz, et al.
Journal of Gastroenterology and Hepatology
|
October 5, 2017
The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury
Ronald G Thurman, Blair U Bradford, Yuji Iimuro, et al.
Acta Neuropathologica
|
November 19, 2015
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Corinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, et al.
The Journal of Clinical Investigation
|
August 4, 2006
The Clinical Research Forum and Association of American Physicians disagree with criticism of the NIH Roadmap
William Crowley, John Courtney, Larry Jameson, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
Elisabeth H Vollmann, Lizhi Cao, Aldo Amatucci, et al.
Alimentary Pharmacology & Therapeutics
|
March 22, 2024
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease
Rohit Loomba, Ginger Clark, Jeff Teckman, et al.
Alimentary Pharmacology & Therapeutics
|
February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Luis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Page
of 13